Literature DB >> 3317822

Alzheimer's drug trial put on hold.

J L Marx.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3317822     DOI: 10.1126/science.3317822

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  7 in total

1.  Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.

Authors:  G Chatellier; L Lacomblez
Journal:  BMJ       Date:  1990-02-24

2.  Effects of tacrine, velnacrine (HP029), suronacrine (HP128), and 3,4-diaminopyridine on skeletal neuromuscular transmission in vitro.

Authors:  M F Braga; A L Harvey; E G Rowan
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

Review 3.  A risk-benefit assessment of tacrine in the treatment of Alzheimer's disease.

Authors:  S C Samuels; K L Davis
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.228

4.  Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze.

Authors:  S Iijima; N H Greig; P Garofalo; E L Spangler; B Heller; A Brossi; D K Ingram
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Application of a brain-targeting chemical delivery system to 9-amino-1,2,3,4-tetrahydroacridine.

Authors:  E Pop; K Prókai-Tátrai; J D Scott; M E Brewster; N Bodor
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

Review 6.  Clinical pharmacokinetics of tacrine.

Authors:  S Madden; V Spaldin; B K Park
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447

7.  Synthesis and in vitro evaluation of N-(Bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine as a cholinesterase inhibitor with regard to Alzheimer's disease treatment.

Authors:  Jan Korabecny; Kamil Musilek; Ondrej Holas; Eugenie Nepovimova; Daniel Jun; Filip Zemek; Veronika Opletalova; Jiri Patocka; Vlastimil Dohnal; Florian Nachon; Jana Hroudova; Zdenek Fisar; Kamil Kuca
Journal:  Molecules       Date:  2010-12-02       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.